ArticleJournal of imaging informatics in medicine2026
Deep Learning for Classification of Solid Renal Parenchymal Tumors Using Contrast-Enhanced Ultrasound.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fusion-Based Deep Learning Approach for Renal Cell Carcinoma Subtype Detection Using Multi-Phasic MRI Data.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study is to assess the ability of deep learning models to classify different subtypes of solid renal parenchymal tumors using contrast-enhanced ultrasound (CEUS) images and to compare their classification performance. A retrospective study was conducted using CEUS images of 237 kidney tumors, including 46 angiomyolipomas (AML), 118 clear cell renal cell carcinomas (ccRCC), 48 papillary RCCs (pRCC), and 25 chromophobe RCCs (chRCC), collected from January 2017 to December 2019. Two deep learning models, based on the ResNet-18 and RepVGG architectures, were trained and validated to distinguish between these subtypes. The models' performance was assessed using sensitivity, specificity, positive predictive value, negative predictive value, F1 score, Matthews correlation coefficient, accuracy, area under the receiver operating characteristic curve (AUC), and confusion matrix analysis. Class activation mapping (CAM) was applied to visualize the specific regions that contributed to the models' predictions. The ResNet-18 and RepVGG-A0 models achieved an overall accuracy of 76.7% and 84.5% across all four subtypes. The AUCs for AML, ccRCC, pRCC, and chRCC were 0.832, 0.829, 0.806, and 0.795 for the ResNet-18 model, compared to 0.906, 0.911, 0.840, and 0.827 for the RepVGG-A0 model, respectively. The deep learning models could reliably differentiate between various histological subtypes of renal tumors using CEUS images in an objective and non-invasive manner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.